The ALRCaN Global (Acute Leukemia Research and Care Network) webinar, titled “Cytopenias Post CAR T-Cells: ALL-Hematotox“, is scheduled for Friday, January 23, 2026, from 09:00 to 10:00 AM ET.

Presented by Dr. Nirali N. Shah, this session focuses on the newly developed ALL-Hematotox (ALL-HT) score, a clinical tool designed to predict hematological toxicity specifically in patients with B-cell acute lymphoblastic leukemia (B-ALL) following CAR T-cell therapy. This weekly collegial gathering, hosted by Resonance, allows experts to share best practices and clinical insights to optimize post-infusion care and patient outcomes.